China Trials - Home
  •  
  •  
  •  
China Pre Trials - Home

2010 SPEAKERS

Confirmed Speakers (as of JuLY 25, 2010)

Kathryn Bayne, Ph.D.
Global Director
AAALAC

Honggang Bi, Ph.D.
Corporate Vice President & General Manager
COVANCE CHINA

Ernest Bush, Ph.D.
Vice President & Scientific Director
CHINA PRECLINICAL MANAGEMENT

Charlene Chen
Director, Center of Toxicology & Preclinical Sciences
DEVELOPMENT CENTER FOR BIOTECHNOLOGY

Mingli Chen, Ph.D.
Vice President, Research
SHANGHAI MEDICILON

John Gong, Ph.D., M.D.
Vice President & CTO
JOINN LABORATORIES

Ming Guo, Ph.D.
Co-Founder & Chief Operating Officer
ASCENTAGE PHARMA GROUP

Deepak Hegde, Ph.D.
Vice President, Formulation Development
WUXI APPTEC

Helen Han Hsu, Ph.D.
Vice President, Head of Preclinical Development- AP
JOHNSON & JOHNSON

Edward Hu, Ph.D.
Chief Operating Officer
WUXI APPTEC

Jing-Shan (Jennifer) Hu, Ph.D.
Director, Licensing & External Research
MERK & CO.

Tina Huang, Ph.D.
Senior Vice President of Operation, Preclinical Services
PHARMARON

Guido Jacobs
Coordinator
BELGIAN GLP MONITORATE

Darren Ji, Ph.D.
Chief Executive Officer
PHARMALEGACY

John Jin, Ph.D.
Vice President, Business Development
TAIGEN BIOTECHNOLOGY

Kewen Jin, Ph.D.
General Manager
CHARLES RIVER LABORATORIES

Ada H.C. Kung, Ph.D.
Senior Vice President, Preclinical Development
TAIGEN BIOTECHNOLOGY

Xian-Ping Lu, Ph.D.
Chief Executive Officer
CHIPSCREEN BIOSCIENCES

Jing Ma, Chief Director
National shanghai center for new drug safety
EVALUATION AND RESEARCH

Mingxin Qian, M.D., Ph.D.
Vice President, DMPK/Preclinical Service
SHANGHAI chempartner

Baoping Wang, Ph.D.
Director, R&D
NOVO NORDISK CHINA

Jianfei Wang, Ph.D.
Director, Laboratory Animal Science
GLAXOSMITHKLINE R&D CHINA

York Xia
Chief Executive Officer
SHANGHAI GENIUS INFORMATION TECH

Stella Xu, Ph.D.
Executive Director
ROCHE

Steve Yang, Ph.D.
Vice President, Head of R&D, Asia
PFIZER CHINA R&D CENTER

James Yan, M.D., Ph.D., DABT
Executive Director./Head of Drug Safety Evaluation
HUTCHISON MEDIPHARMA

Yi Yang, M.D., Ph.D.
Head of Preclinical Safety, China R&D
SANOFI-AVENTIS CHINA

Hequn Yin, Ph.D.
Head of DMPKS
NOVARTIS CHINA

Zuoxiang Yu, Ph.D.
Alliance GLP Management Support Director
ASTRAZENECA CHINA

Joe Zhang, M.D., Ph.D.
Head of DMPKS
ROCHE R&D CENTER CHINA

Nick Zhang, Ph.D.
Head of CPP/PHAD, China
NOVARTIS CHINA

Xun Zhang, Ph.D.
SVP, Non-Clinical Development & Project Operations
HUTCHISON MEDIPHARMA

We are currently researching the topics and speakers that will be featured at CHINA PRETRIALS 2010. If you would like to suggest a topic to cover or be considered for a speaking role at the 2010 meeting, please contact James Prudhomme at jprudhomme@healthtech.com.


Send me event updates Copyright © 2009 Lychee Group LLC. All rights reserved.

*You must register through Cambridge Healthtech Institute to save 10% off your registration.
This discount does not apply to previously registered attendees. This is NOT a CHI event.